Freestone Grove Partners’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-867,709
Closed -$65.2M 806
2025
Q3
$65.2M Buy
867,709
+17,557
+2% +$1.31M 0.49% 54
2025
Q2
$63M Buy
850,152
+104,313
+14% +$7.26M 0.48% 60
2025
Q1
$60.2M Buy
+745,839
New +$64.1M 0.62% 39

Other funds holding GEHC

Freestone Grove Partners's GEHC Position: Q4 2025 in Review

Freestone Grove Partners sold out of GE HealthCare (GEHC) in Q4 2025, closing a stake of 867,709 shares — an estimated $65.2M sold.

Freestone Grove Partners first reported a position in GEHC in Q1 2025 and held it in 3 quarters. The position peaked at $65.2M in Q3 2025. 1,333 funds tracked by Wall St. Rank hold GEHC as of Q4 2025.

  • Freestone Grove Partners reported no remaining GE HealthCare position as of Q4 2025 after selling out during the quarter.
  • Freestone Grove Partners sold 867,709 GE HealthCare shares in Q4 2025, an estimated $65.2M.
  • Freestone Grove Partners first reported a position in GE HealthCare in Q1 2025 and held it in 3 quarters.
  • Freestone Grove Partners's GE HealthCare position peaked at $65.2M in Q3 2025.
  • 1,333 funds tracked by Wall St. Rank held GE HealthCare as of Q4 2025.

Based on Freestone Grove Partners's 13F filing for Q4 2025, filed 17 Feb 2026.